Source: EURLEX
Language: en
Format: md

C 33/2 EN Official Journal of the European Communities 1.2.2001

Prior notification of a concentration

(Case COMP/M.2312 �Abbott/BASF)

(2001/C 33/02)

(Text with EEA relevance)

1. On 26 January 2001 the Commission received notification of a proposed concentration pursuant to
Article 4 of Council Regulation (EEC) No 4064/89 ( [1] ), as last amended by Regulation (EC) No 1310/97 ( [2] ),
by which the undertaking Abbott Laboratories (USA) acquires, within the meaning of Article 3(1)(b) of the
Regulation, control of the pharmaceutical business of the undertaking BASF (Germany), consisting of,
amongst others, BASF Pharmaceutical Corporation, Knoll AG and Knoll GmbH, by way of purchase of
voting securities and assets.

2. The business activities of the undertakings concerned are:

�Abbott Laboratories: global health care company (pharmaceutical, nutritional, hospital and diagnostic
products),

�BASF: global company active in chemical, health and nutrition, oil and gas sectors.

3. On preliminary examination, the Commission finds that the notified concentration could fall within
the scope of Regulation (EEC) No 4064/89. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the
proposed operation.

Observations must reach the Commission not later than 10 days following the date of this publication.
Observations can be sent by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference
COMP/M.2312 �Abbott/BASF, to:

European Commission,
Directorate-General for Competition,
Directorate B �Merger Task Force,
Rue Joseph II/Jozef II-straat 70,
B-1000 Brussels.

( [1] ) OJ L 395, 30.12.1989, p. 1; corrigendum: OJ L 257, 21.9.1990, p. 13.
( [2] ) OJ L 180, 9.7.1997, p. 1; corrigendum: OJ L 40, 13.2.1998, p. 17.